On May 28th, 2009, the Corporate Advisory Committee met with industry representatives to clarify disclosure and compliance protocols in physician-industry relations. It was somewhat prophetic that The Charleston Gazette headline read: "Drug company spending due today – some doctors received over $100,000 in ’08." This article documented companies which spent $16 million in direct consumer advertising and gave $16,000 in gifts, grants, or payments to physicians. There was no differentiation between CME support, research grants, royalties, or consulting, and the vast majority were between $50 and $1,250. Compliance and disclosure protocols were discussed from the perspective of health systems, universities, physicians, and industry.
How does this affect your society and you? First, you must understand conflict of interest (COI) and how it impacts you. There are moral, ethical and legal ramifications of COI issues. Morally and ethically, the litmus test is to do no harm to patients, hospitals, or insurance companies. "Harm" is not just physical but also economic. Additionally, you are not the customer because you do not pay for the product; but you select it, implant it, or prescribe it.
Multiple conflicts exist – including ego, but money is the most easily recognized and analyzed issue. For publications and presentations, the average monetary threshold is $500. The threshold for most institutional review boards for research (clinical and basic) is typically about $10,000. Above this amount, manageable conflicts fall between $10,000- 40,000 on average; and unmanageable levels exceed $40,000. Salaries from research grants are excluded.
There are no absolutes; however, following proper disclosure protocols is your best defense. Beware; disclose industry support to your hospital purchasing departments when asking them to stock products. Lastly, consider telling your patients if you have significant support from a company whose implant or drug you are recommending.
Recent Comments